Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > BMY > Summary

Bristol-Myers Squibb Co.
(BMY)

24.25USD   Up0.29 (1.21%)   
At 2:30AM IST
 Bristol-Myers Squibb Co. (NYSE:BMY) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 24.25USD
Trade Time:2:30AM IST
Change:Up0.29 (1.21%)
Prev Close:23.96
Open:24.10
Bid:N/A
Ask:N/A
1y Target Est:24.99
Day's Range:23.90 - 24.41
52wk Range:17.23 - 26.62
Volume:9,906,506
Avg Vol (3m):26,002,100
Market Cap:48.04B
P/E (ttm):12.55
EPS (ttm):1.93
Div & Yield:1.25 (5.22%)
Add BMY to Portfolio   Download Data

HEADLINES

 
•Pfizer Off 2% As 2010 Targets Miss; Posts Revised 2012 Targets - Barrons.com  - Wed 6:50AM
•Researchers find sex-specific lung cancer genes - Reuters  - Wed 6:04AM
•How Much Should Cancer Drugs Cost? - The Wall Street Journal Online  - Wed 2:35AM
•Make Thousands From Millions - Motley Fool  - Tue 11:50PM
•UPDATE - U.S. FDA staff questions small ChemGenex study - Reuters  - Tue 6:27AM
•UK says Novartis, Bristol cancer drugs too costly - Reuters  - Tue 5:31AM
•Monday Options Recap: Volatility Eases - Seeking Alpha  - Tue 2:25AM
•Correction is Healthy - and a Buying Opportunity: Strategist - CNBC  - Mon, Feb 8
•AMRI reports $19M net loss in 4Q - bizjournals.com  - Mon, Feb 8
•UPDATE - U.S. FDA staff questions small ChemGenex study - Reuters  - Mon, Feb 8
•How Big Pharma Got in This Fix - Seeking Alpha  - Sun, Feb 7
•Bristol-Myers Squibb to freeze salaries in 2010 - AP  - Sat, Feb 6
•Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo - The New York Times  - Fri, Feb 5
•Why Pharma's Patent Cliff Is Good News for Pharmacies - The Wall Street Journal Online  - Fri, Feb 5
•[$$] Cost Cutting Boosts Profits - The Wall Street Journal Online  - Fri, Feb 5
» More Headlines for BMY...

ANALYST

 
EPS Est (next year) (Dec-09) :1.78
EPS Est (in 2 years) (Dec-10) :2.21
Avg Rec (current)*:2.6
PEG Ratio:5.21
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Bristol-Myers Squibb Company (BMS) engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of pharmaceuticals and nutritional products worldwide.

» Full Company Profile